MEDIFAST INC (MED): Price and Financial Metrics


-2.72 (-3.25%)

POWR Rating

Component Grades








Add MED to Watchlist
Sign Up

Industry: Medical - Consumer Goods




#4 of 7

in industry

MED Price/Volume Stats

Current price $80.87 52-week high $192.44
Prev. close $83.59 52-week low $77.67
Day low $79.56 Volume 81,653
Day high $81.70 Avg. volume 208,349
50-day MA $91.68 Dividend yield 8.32%
200-day MA $109.90 Market Cap 880.43M

MED Stock Price Chart Interactive Chart >


  • Quality is the dimension where MED ranks best; there it ranks ahead of 99.64% of US stocks.
  • MED's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • MED's current lowest rank is in the Sentiment metric (where it is better than 8.07% of US stocks).

MED Stock Summary

  • MEDIFAST INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 95.71% of US listed stocks.
  • For MED, its debt to operating expenses ratio is greater than that reported by merely 7.56% of US equities we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MED comes in at 21.5% -- higher than that of 91.44% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEDIFAST INC are LEJU, RYI, VRTV, ENG, and SPWH.
  • Visit MED's SEC page to see the company's official filings. To visit the company's web site, go to

MED Valuation Summary

  • MED's price/sales ratio is 0.6; this is 25% lower than that of the median Consumer Cyclical stock.
  • Over the past 243 months, MED's price/earnings ratio has gone down 27.8.

Below are key valuation metrics over time for MED.

Stock Date P/S P/B P/E EV/EBIT
MED 2023-05-19 0.6 5.7 6.9 4.8
MED 2023-05-18 0.6 5.8 7.0 4.9
MED 2023-05-17 0.6 5.8 6.9 4.8
MED 2023-05-16 0.6 5.7 6.9 4.8
MED 2023-05-15 0.7 5.8 7.0 4.9
MED 2023-05-12 0.6 5.7 6.8 4.7

MED Growth Metrics

    The year over year price growth rate now stands at -22.43%.
  • Its year over year cash and equivalents growth rate is now at -42.73%.
  • The year over year revenue growth rate now stands at 46.12%.
MED's revenue has moved up $1,325,766,000 over the prior 70 months.

The table below shows MED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,598.577 194.57 143.568
2022-09-30 1,639.165 135.372 151.072
2022-06-30 1,662.162 95.776 156.899
2022-03-31 1,603.018 72.892 164.749
2021-12-31 1,526.087 94.545 164.031
2021-09-30 1,413.165 121.833 158.002

MED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MED has a Quality Grade of A, ranking ahead of 99.43% of graded US stocks.
  • MED's asset turnover comes in at 4.143 -- ranking 1st of 59 Food Products stocks.
  • TWNK, TOFB, and KHC are the stocks whose asset turnover ratios are most correlated with MED.

The table below shows MED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 4.143 0.744 19.148
2021-03-31 4.006 0.739 72.885
2020-12-31 3.851 0.746 8.172
2020-09-30 3.779 0.746 4.378
2020-06-30 3.670 0.745 2.384
2020-03-31 3.596 0.753 1.821

MED Price Target

For more insight on analysts targets of MED, see our MED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $363.33 Average Broker Recommendation 1.33 (Strong Buy)


Medifast Inc. is a manufacturer and provider of clinically weight-loss and weight-maintenance products and programs. The company was founded in 1980 and is based in Owings Mills, Maryland.

MED Latest News Stream

Event/Time News Detail
Loading, please wait...

MED Latest Social Stream

Loading social stream, please wait...

View Full MED Social Stream

Latest MED News From Around the Web

Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.

7 Safe High-Yield Dividend Stocks to Buy in June 2023

While it’s extremely difficult to have your cake and eat it too, these top safe high-yield dividend stocks may accomplish just that.

Josh Enomoto on InvestorPlace | June 1, 2023

Medifast (MED) Down 8.2% Since Last Earnings Report: Can It Rebound?

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | May 31, 2023

Investors one-year losses continue as Medifast (NYSE:MED) dips a further 8.6% this week, earnings continue to decline

Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...

Yahoo | May 29, 2023

15 Best Diets in 2023

In this article, we will be taking a look at the 15 best diets in 2023. To skip our detailed analysis, you can go directly to see 5 Best Diets in 2023. Regardless of whether someone is focused on cardiovascular health, weight loss, or simply a more balanced eating plan, choosing the best diet can […]

Yahoo | May 5, 2023

Medifast, Inc. (NYSE:MED) Q1 2023 Earnings Call Transcript

Medifast, Inc. (NYSE:MED) Q1 2023 Earnings Call Transcript May 1, 2023 Medifast, Inc. beats earnings expectations. Reported EPS is $3.67, expectations were $2.4. Operator: Good afternoon, and welcome to the Medifast First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. […]

Yahoo | May 4, 2023

Read More 'MED' Stories Here

MED Price Returns

1-mo -11.10%
3-mo -22.82%
6-mo -30.40%
1-year -53.67%
3-year -20.48%
5-year -38.59%
YTD -28.68%
2022 -42.31%
2021 9.36%
2020 86.18%
2019 -9.73%
2018 82.11%

MED Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MED Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!